European Journal of Cancer
Volume 41, Issue 14 , Pages 2071-2078 , September 2005

Cancer staging and survival in colon cancer is dependent on the quality of the pathologists’ specimen examination

  • P. Jestin

      Affiliations

    • The Department of Surgical Sciences, Akademiska sjukhuset, Colorectal Unit, Uppsala University, SE 751 85, Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Fax: +46 18 6114632.
    • ,
  • L. Påhlman

      Affiliations

    • The Department of Surgical Sciences, Akademiska sjukhuset, Colorectal Unit, Uppsala University, SE 751 85, Uppsala, Sweden
    • ,
  • B. Glimelius

      Affiliations

    • Department of Oncology, Radiology and Clinical Immunology, Akademiska sjukhuset, Uppsala University, Uppsala, Sweden
    • ,
  • U. Gunnarsson

      Affiliations

    • The Department of Surgical Sciences, Akademiska sjukhuset, Colorectal Unit, Uppsala University, SE 751 85, Uppsala, Sweden

Received 15 December 2004 ,Revised 26 May 2005 ,Accepted 16 June 2005.

References 

  1. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol. 1932;35:323–332
  2. American Joint Committee on Cancer. Cancer staging manual. 5th ed. 2003. p. 83–90.
  3. Ragnhammar P, Hafstom L, Nygren P, et al. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol. 2001;40(2–3):282–308
  4. Taal BG, Van Tinteren H, Zoetmulder FA. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stages II and III. Br J Cancer. 2001;85(10):1437–1443
  5. Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?. J Clin Oncol. 2004;22(10):1797–1806
  6. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6(4):325–344
  7. Holm T, Johansson H, Cedermark B, et al. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg. 1997;84(5):657–663
  8. Dahlberg M, Glimelius B, Påhlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg. 1999;86(3):379–384
  9. Wibe A, Møller B, Carlsen J, et al. A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45(7):857–866
  10. Kapiteijn E, Putter H, Van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89(9):1142–1149
  11. Gunnarsson U. Quality assurance in surgical oncology. Colorectal cancer as an example. Eur J Surg Oncol. 2003;29(1):89–94
  12. Nagtegaal ID, Van de Velde CJ, Van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20(7):1729–1734
  13. Glimelius B, Gronberg H, Jarhult J, et al. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol. 2003;42(5–6):476–492
  14. Hernanz F, Revuelta S, Redondo C, et al. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum. 1994;37(4):373–376Discussion 376
  15. Wong JH, Severino R, Honnebier MB, et al. Number of nodes examined and staging accuracy incolorectal carcinoma. J Clin Oncol. 1999;17(9):2896–2900
  16. Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved onresection. Ann Surg Oncol. 2003;10(3):213–218
  17. Jestin P, Heurgren M, Påhlman L, et al. Elective surgery for colorectal cancer in a defined Swedish population. Eur J Surg Oncol. 2004;30(1):26–33
  18. Mella J, Biffin A, Radcliffe AG, et al. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit Population-based audit of colorectal cancer managementin two UK health regions. Br J Surg. 1997;84(12):1731–1736
  19. Kyllonen LE. Carcinoma of the colon in Finland. A nation-wide clinical study of cases from 1975. Acta Chir Scand. 1987;153(2):123–131
  20. Benson AB, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408–3419
  21. Figueredo A, Charette ML, Maroun J, et al. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol. 2004;22(16):3395–3407
  22. Cox DR. Regression model and life-tables. J Roy Stat Soc Brit. 1972;34:187–220
  23. Gunnarsson U, Seligsohn E, Jestin P, et al. Registration and validity of surgical complications in colorectal cancer surgery. Br J Surg. 2003;90(4):454–459
  24. Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10(1):65–71
  25. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21(15):2912–2919
  26. Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235(4):458–463
  27. O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–1425
  28. Greene FL, Stewart AK, Norton HJ. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. J Clin Oncol. 2004;22(10):1778–1784
  29. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22(10):1785–1796
  30. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA. 2004;291(19):2359–2366
  31. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–2351

PII: S0959-8049(05)00546-0

doi: 10.1016/j.ejca.2005.06.012

European Journal of Cancer
Volume 41, Issue 14 , Pages 2071-2078 , September 2005

Article Tools

* Image Usage & Resolution